11/22/2013 - (PACB), a filing with the SEC revealed that on Thursday, Chairman Michael Hunkapiller bought 200,000 shares of PACB, for a cost of $3.61 each, for a total investment of $721,680. So far Hunkapiller is in the green, up about 14.4% on their buy based on today’s trading high of $4.13. Before this latest buy, Hunkapiller purchased PACB at 3 other times during the past year, for a total investment of $946,113 at an average of $1.62 per share.
(0)
(0)
Pacific Biosciences Of California (PACB) Stock Research Links